Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
Medical Clinic and Polyclinic II, Center for Internal Medicine, University Hospital Wuerzburg, Oberdürrbacher Straße 6, House A3, 97080, Würzburg, Germany.
Support Care Cancer. 2022 Nov;30(11):9615-9623. doi: 10.1007/s00520-022-07369-9. Epub 2022 Oct 3.
Multiple myeloma (MM) is a severe hemato-oncological disease with high mortality and increasing incidence rate. Since evidence on exercise therapy in MM patients remains limited, this study examines feasibility, adherence, and efficacy based on real-life data from an oncologic care structure.
A data evaluation of MM patients who participated in the oncologic exercise and movement therapy (OTT) at the Cologne University Hospital between 2012 and 2019 was conducted. The patient flow was incrementally reduced to four cohorts, intention-to-treat cohort (ITTC), safety cohort (SC), adherence cohort (AC), and efficacy cohort (EC). Cohorts were evaluated descriptively and by means of correlation analysis as well as group and time comparisons.
Thirty patients registered at the OTT between 2012 and 2019 (ITTC). The SC (N = 26) attended exercise therapy on average about one session per week over a period of 8 months. One-third dropped out within 3 months. In the AC (N = 15), BMI at baseline exhibited a strong and very significant negative correlation with exercise adherence. In the EC (N = 8), a significant improvement in physical functioning and a tendency towards significance in fatigue reduction between two measurement points was observed. No adverse events were documented.
The present observatory study reveals safety and feasibility while indicating adherence and efficacy of exercising MM patients under real-life therapy circumstances. Found obstacles to exercising as well as improvements in questionnaire scale scores need to be further examined in confirmatory study designs.
多发性骨髓瘤(MM)是一种严重的血液肿瘤疾病,死亡率高,发病率不断上升。由于 MM 患者运动疗法的证据仍然有限,本研究基于肿瘤治疗结构的真实数据,考察其可行性、依从性和疗效。
对 2012 年至 2019 年期间在科隆大学医院参加肿瘤运动和治疗(OTT)的 MM 患者进行数据评估。患者流量逐渐减少至四个队列,意向治疗队列(ITTC)、安全队列(SC)、依从性队列(AC)和疗效队列(EC)。对队列进行描述性评估,并进行相关性分析以及组间和时间比较。
2012 年至 2019 年期间,OTT 注册患者共 30 例(ITTC)。SC(N=26)平均每周参加一次运动治疗,持续 8 个月。三分之一的患者在 3 个月内退出。在 AC(N=15)中,基线 BMI 与运动依从性呈强且非常显著的负相关。在 EC(N=8)中,在两个测量点之间观察到身体功能显著改善,疲劳减轻趋势具有统计学意义。未记录到不良事件。
本观察性研究揭示了在真实治疗环境下,MM 患者进行运动的安全性和可行性,同时表明了其依从性和疗效。需要进一步在验证性研究设计中检查运动障碍以及问卷量表评分的改善。